As Therapeutic Modalities Expand, Genomic Profiling Must Keep Pace

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 04 Nov, 20:49 UTC

The boundaries of what’s considered “druggable” are shifting as advances in cell and gene therapies expand the possibilities for cancer treatment. Expanded insights can open new avenues for biomarker research and therapeutic discovery. The post As Therapeutic Modalities Expand, Genomic Profiling…

science

Sources

• T2As Therapeutic Modalities Expand, Genomic Profiling Must Keep PaceFierce Biotech / Fierce Healthcare / MedCity / GEN04 Nov, 20:49